Immunonephelometric determination of fibrinogen on citrated or heparinized plasma: Comparison with functional Clauss method

Clinical Laboratory

Volumn 51, Issue 5-6, 2005, Pages 285-288

  Bargnoux, A S ^a   Dupuy, A M ^a   Biron Andreani C ^b   Schved, J F ^b   Cristol, Jean Paul ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Activity; Antigen; Citrated plasma; Fibrinogen; Heparinized plasma; Immunonephelometry; von Clauss

Indexed keywords

ANTIGEN; CITRATE TRISODIUM; FIBRINOGEN; HEPARIN;

ACCURACY; ANALYTIC METHOD; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEPHELOMETRY; PLASMA; PROTEIN FUNCTION; RELIABILITY; TUBE; VALIDATION PROCESS;

BLOOD SPECIMEN COLLECTION; CITRATES; FIBRINOGEN; HEPARIN; IMMUNOASSAY; METHODS; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS;

EID: 21244459963     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Mackie I, Kitchen S, Machin S, Lowe G. Guidelines on fibrinogen assays. British Journal of Haematology 2003; 121:396-404.
2. Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature. Ann Intern Med 1993; 118:956-63.
3. Maresca G, Di Blasio A, Marchioli R, Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update. 1999; 19:1368-1377.
4. Sweetnam PM, Yarnell JWG, Lowe GDO, Baker IA, O'Brien LR, Rumley A, Etherington MD, Whitehead PJ and Elwood PC. The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies. British Journal of Haematology 1998; 100: 582-588.
5. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, Massaro JM, Wilson PFW, Muller JE, D'Agostino RB. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation 2000; 102:1634-38.
6. Lowe GD, Rumley A, Mackie J. Plasma fibrinogen. Ann Clin Biochem 2004; 41 (Pt 6):430-40.
7. Palareti G, Maccaferri M, Manotti C, Tripodi A, Chantarangkul V, Rodeghiero, Ruggeri M, and Mannucci PM. Fibrinogen assays: A collaborative study of six different methods. Clin Chem 1991; 37:714-9
8. Magnani B, Fenton T, Lapp C and Brugnara C. Degree of agreement in plasma fibrinogen among two functional and one immunonephelometric assays. Am J Clin Pathol 1997; 107(5):527-33.
9. Rumley A, Woodward M, Hoffmeister, Koenig W, Lowe GD. Comparison of plasma fibrinogen by Clauss, prothrombin time-derived and immunonephelometric assays in the general population: implications for risk stratification by thirds of fibrinogen. Blood Coag Fibrinolysis 2003; 14:197-201.